Taiwo Oluwatosin Omolase/LinkedIn
Mar 5, 2026, 14:07
Taiwo Oluwatosin Omolase: How Data-Driven Risk Stratification Can Support Early Stroke Detection and Prevention
Taiwo Oluwatosin Omolase, Data Analyst at Kinplus Technologies, shared on LinkedIn:
”Stroke Risk Analytics Dashboard | Healthcare Data Project
I recently analyzed 5,109 patient records from the Kaggle Stroke Prediction Dataset to explore patterns in stroke occurrence.
Key Findings:
- Total Stroke Cases: 249 (4.87%)
- Average Stroke Age: 67.7 years
- Female patients recorded more stroke cases (141 vs 108 males)
- 73% of stroke patients had no diagnosed hypertension
- Age 60+ consistently showed stronger association with stroke occurrence.
What This Project Reinforced:
- Raw counts can be misleading in healthcare analytics.
- Risk interpretation requires subgroup rate calculations, not just frequency.
- For example, while a large number of stroke cases appeared in older non smokers without hypertension, this may reflect population distribution rather than elevated individual risk.
Tools Used:
Power BI | DAX
As a pharmacist with growing interest in healthcare analytics, I am particularly passionate about how datadriven risk stratification can support early detection and preventive medicine.
I welcome feedback from healthcare professionals and data scientists.”
Stay updated on all scientific advances with Hemostasis Today.
-
Oct 18, 2026, 02:43Priya Sriskandarajah: Diagnosis and Management of PV and JAK2-Unmutated Erythrocytosis
-
Oct 18, 2026, 02:41C. Michael Gibson: A Meta-Analysis of DOACs and DAPT After Left Atrial Appendage Closure
-
Oct 18, 2026, 02:27What Hematologists Should Remember About the Person Behind the Platelet Count – ASH
-
Oct 18, 2026, 01:44Marta Velia Antonini: How to Deliver CRRT during ECMO?
-
Oct 18, 2026, 01:19Aamir Saeed: Anticoagulation, Cirrhosis, and Other Risk Factors for Post-ERCP Bleeding
-
Oct 18, 2026, 00:33Elad Asher: Does Opening the Clot Change How a Patient Feels Three Months Later?
-
Oct 18, 2026, 00:22Richa Sharma: Evaluating Heterogeneity in Anticoagulation Treatment Effects in Cryptogenic Stroke
-
Oct 18, 2026, 00:07Irem Karaman Sebin: The Evidence Favoring Warfarin in High-Risk Antiphospholipid Syndrome
-
Oct 18, 2026, 00:07Emma Stevens: Lighting Up Buildings in Red and Blue for World Thrombosis Day